Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
BlossomHill Therapeutics, Inc.
Market Cap
$502.81M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$503.93M
EBITDA Margin
-1179818.18%
TTM Avg
-754929.09%
3Y Avg
-428982.67%
5Y Avg
-428982.67%
Market Cap
$504.04M
EBITDA Margin
-1406.75%
TTM Avg
-1406.75%
3Y Avg
-151851.64%
5Y Avg
-92301.39%
Market Cap
$500.52M
EBITDA Margin
10.90%
TTM Avg
10.39%
3Y Avg
7.60%
5Y Avg
5.15%
Market Cap
$505.87M
EBITDA Margin
-35.08%
TTM Avg
-77.94%
3Y Avg
-77.08%
5Y Avg
-62.83%
Market Cap
$498.52M
EBITDA Margin
-10611.95%
TTM Avg
-10611.95%
3Y Avg
-10611.95%
5Y Avg
-10611.95%
Market Cap
$516.76M
EBITDA Margin
-970.11%
TTM Avg
-861.99%
3Y Avg
-583.02%
5Y Avg
-735.09%
Market Cap
$519.25M
EBITDA Margin
-230187.80%
TTM Avg
-372428.90%
3Y Avg
-255754.79%
5Y Avg
-154022.75%
Market Cap
$486.01M
EBITDA Margin
-9.71%
TTM Avg
-10.19%
3Y Avg
-20.82%
5Y Avg
-63.11%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $502.81M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | -1179818.18% | -754929.09% | -428982.67% | -428982.67% |
| Crescent Biopharma, Inc. (CBIO)vs › | $504.04M | -1406.75% | -1406.75% | -151851.64% | -92301.39% |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 10.90% | 10.39% | 7.60% | 5.15% |
| 908 Devices Inc. (MASS)vs › | $505.87M | -35.08% | -77.94% | -77.08% | -62.83% |
| Oculis Holding AG (OCS)vs › | $498.52M | -10611.95% | -10611.95% | -10611.95% | -10611.95% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | -970.11% | -861.99% | -583.02% | -735.09% |
| Altimmune, Inc. (ALT)vs › | $519.25M | -230187.80% | -372428.90% | -255754.79% | -154022.75% |
| Evolus, Inc. (EOLS)vs › | $486.01M | -9.71% | -10.19% | -20.82% | -63.11% |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 21.12% | 19.78% | 18.26% | 11.49% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
